We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
CYTO365 is proud to yet again be a sponsor of this event.
This conference is open to clinical governance, healthcare managers, nurses, pharmacists, workers’ rights entities and healthcare establishments from across Europe, the UK, and focusses on current scientific evidence, the risks to health, and best practice, and the future responsibilities of employers regards hazardous drug exposure management and in line with the recently published ISOPP Standards for the Safe Handling of Cytotoxics 2022, the EU Guidance for the Safe Management of Hazardous Medicinal Products at work 2023, and the ETUI (European Trade Union Institute) List of Hazardous Medicinal Products 2022.
https://www.safercancercare.com/about-the